Wayne Godfrey
2022
In 2022, Wayne Godfrey earned a total compensation of $2.3M as Chief Medical Officer at Janux Therapeutics, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,400 |
|---|---|
| Option Awards | $1,660,738 |
| Salary | $435,000 |
| Total | $2,287,138 |
Godfrey received $1.7M in option awards, accounting for 73% of the total pay in 2022.
Godfrey also received $191.4K in non-equity incentive plan and $435K in salary.
Rankings
In 2022, Wayne Godfrey's compensation ranked 1,578th out of 5,760 executives tracked by ExecPay. In other words, Godfrey earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,578 out of 5,760 | 73rd |
Division Manufacturing | 806 out of 3,136 | 74th |
Major group Chemicals And Allied Products | 318 out of 1,422 | 78th |
Industry group Drugs | 295 out of 1,323 | 78th |
Industry Pharmaceutical Preparations | 209 out of 969 | 78th |
Source: SEC filing on April 28, 2023.
Godfrey's colleagues
We found two more compensation records of executives who worked with Wayne Godfrey at Janux Therapeutics in 2022.